Instability at the FRA8I common fragile site disrupts the genomic integrity of the KIAA0146, CEBPD and PRKDC genes in colorectal cancer

Cancer Letters

Volumn 336, Issue 1, 2013, Pages 85-95

  Brueckner, Lena M ^a   Hess, Elisa M ^a   Schwab, Manfred ^a   Savelyeva, Larissa ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

BCP ALL; DNA PKcs; IGH translocation; Isochromosome 8q; L1 (LINE)

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CEBPD GENE; CHROMOSOME 8Q; CHROMOSOME FRAGILE SITE; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA PROBE; DNA SEQUENCE; EPITHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DOSAGE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE STRUCTURE; GENETIC CODE; GENETIC RECOMBINATION; GENOMIC INSTABILITY; KIAA0146 GENE; LYMPHOCYTE; MOLECULAR SIZE; PRIORITY JOURNAL; PRKDC GENE;

CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; CHROMOSOME FRAGILE SITES; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 8; COLORECTAL NEOPLASMS; DNA-ACTIVATED PROTEIN KINASE; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEAR PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; TRANSLOCATION, GENETIC;

EID: 84878990826     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.04.007     Document Type: Article

References (75)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
2. Drier Y., Lawrence M.S., Carter S.L., Stewart C., Gabriel S.B., Lander E.S., Meyerson M., Beroukhim R., Getz G. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res. 2012.
3. Camps J., Grade M., Nguyen Q.T., Hormann P., Becker S., Hummon A.B., Rodriguez V., Chandrasekharappa S., Chen Y., Difilippantonio M.J., Becker H., Ghadimi B.M., Ried T. Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res. 2008, 68:1284-1295.
4. Dulak A.M., Schumacher S.E., van Lieshout J., Imamura Y., Fox C., Shim B., Ramos A.H., Saksena G., Baca S.C., Baselga J., Tabernero J., Barretina J., Enzinger P.C., Corso G., Roviello F., Lin L., Bandla S., Luketich J.D., Pennathur A., Meyerson M., Ogino S., Shivdasani R.A., Beer D.G., Godfrey T.E., Beroukhim R., Bass A.J. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res. 2013, 72:4383-4393.
5. Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F., Campbell P.J., Futreal P.A., Stratton M.R. Signatures of mutation and selection in the cancer genome. Nature 2010, 463:893-898.
6. Mrasek K., Schoder C., Teichmann A.C., Behr K., Franze B., Wilhelm K., Blaurock N., Claussen U., Liehr T., Weise A. Global screening and extended nomenclature for 230 aphidicolin-inducible fragile sites, including 61 yet unreported ones. Int. J. Oncol. 2010, 36:929-940.
7. Ferber M.J., Thorland E.C., Brink A.A., Rapp A.K., Phillips L.A., McGovern R., Gostout B.S., Cheung T.H., Chung T.K., Fu W.Y., Smith D.I. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 2003, 22:7233-7242.
8. Glover T.W. Common fragile sites. Cancer Lett. 2006, 232:4-12.
9. Dillon L.W., Burrow A.A., Wang Y.H. DNA instability at chromosomal fragile sites in cancer. Curr. Genomics 2010, 11:326-337.
10. Halazonetis T.D., Gorgoulis V.G., Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008, 319:1352-1355.
11. Tsantoulis P.K., Kotsinas A., Sfikakis P.P., Evangelou K., Sideridou M., Levy B., Mo L., Kittas C., Wu X.R., Papavassiliou A.G., Gorgoulis V.G. Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study. Oncogene 2008, 27:3256-3264.
12. Glover T.W., Berger C., Coyle J., Echo B. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 1984, 67:136-142.
13. Casper A.M., Nghiem P., Arlt M.F., Glover T.W. ATR regulates fragile site stability. Cell 2002, 111:779-789.
14. Durkin S.G., Glover T.W. Chromosome fragile sites. Annu. Rev. Genet. 2007, 41:169-192.
15. Schwartz M., Zlotorynski E., Goldberg M., Ozeri E., Rahat A., le Sage C., Chen B.P., Chen D.J., Agami R., Kerem B. Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev. 2005, 19:2715-2726.
16. Pirzio L.M., Pichierri P., Bignami M., Franchitto A. Werner syndrome helicase activity is essential in maintaining fragile site stability. J. Cell Biol. 2008, 180:305-314.
17. Arlt M.F., Glover T.W. Inhibition of topoisomerase I prevents chromosome breakage at common fragile sites. DNA Repair (Amst.) 2010, 9:678-689.
18. Ragland R.L., Glynn M.W., Arlt M.F., Glover T.W. Stably transfected common fragile site sequences exhibit instability at ectopic sites. Genes, Chromosomes Cancer 2008, 47:860-872.
19. Zlotorynski E., Rahat A., Skaug J., Ben-Porat N., Ozeri E., Hershberg R., Levi A., Scherer S.W., Margalit H., Kerem B. Molecular basis for expression of common and rare fragile sites. Mol. Cell. Biol. 2003, 23:7143-7151.
20. Burrow A.A., Marullo A., Holder L.R., Wang Y.H. Secondary structure formation and DNA instability at fragile site FRA16B. Nucl. Acids Res. 2010, 38:2865-2877.
21. Le Beau M.M., Rassool F.V., Neilly M.E., Espinosa R., Glover T.W., Smith D.I., McKeithan T.W. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction. Hum. Mol. Genet. 1998, 7:755-761.
22. Jiang Y., Lucas I., Young D.J., Davis E.M., Karrison T., Rest J.S., Le Beau M.M. Common fragile sites are characterized by histone hypoacetylation. Hum. Mol. Genet. 2009, 18:4501-4512.
23. Letessier A., Millot G.A., Koundrioukoff S., Lachages A.M., Vogt N., Hansen R.S., Malfoy B., Brison O., Debatisse M. Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 2011, 470:120-123.
24. Debatisse M., Le Tallec B., Letessier A., Dutrillaux B., Brison O. Common fragile sites: mechanisms of instability revisited. Trends Genet. 2012, 28:22-32.
25. Ozeri-Galai E., Lebofsky R., Rahat A., Bester A.C., Bensimon A., Kerem B. Failure of origin activation in response to fork stalling leads to chromosomal instability at fragile sites. Mol. Cell 2011, 43:122-131.
26. Ozeri-Galai E., Bester A.C., Kerem B. The complex basis underlying common fragile site instability in cancer. Trends Genet. 2012, 28:295-302.
27. Arlt M.F., Durkin S.G., Ragland R.L., Glover T.W. Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst.) 2006, 5:1126-1135.
28. Lewandowska U., Zelazowski M., Seta K., Byczewska M., Pluciennik E., Bednarek A.K. WWOX, the tumour suppressor gene affected in multiple cancers. J. Physiol. Pharmacol. 2009, 60(Suppl. 1):47-56.
29. Saldivar J.C., Shibata H., Huebner K. Pathology and biology associated with the fragile FHIT gene and gene product. J. Cell. Biochem. 2010, 109:858-865.
30. Gandhi M., Dillon L.W., Pramanik S., Nikiforov Y.E., Wang Y.H. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene 2010, 29:2272-2280.
31. Nagoshi H., Taki T., Hanamura I., Nitta M., Otsuki T., Nishida K., Okuda K., Sakamoto N., Kobayashi S., Yamamoto-Sugitani M., Tsutsumi Y., Kobayashi T., Matsumoto Y., Horiike S., Kuroda J., Taniwaki M. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality. Cancer Res. 2012, 72:4954-4962.
32. Hellman A., Zlotorynski E., Scherer S.W., Cheung J., Vincent J.B., Smith D.I., Trakhtenbrot L., Kerem B. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 2002, 1:89-97.
33. Cicek M.S., Slager S.L., Achenbach S.J., French A.J., Blair H.E., Fink S.R., Foster N.R., Kabat B.F., Halling K.C., Cunningham J.M., Cerhan J.R., Jenkins R.B., Boardman L.A., Petersen G.M., Sargent D.J., Alberts S.R., Limburg P.J., Thibodeau S.N. Functional and clinical significance of variants localized to 8q24 in colon cancer. Cancer Epidemiol Biomarkers Prev. 2009, 18:2492-2500.
34. Blumrich A., Zapatka M., Brueckner L.M., Zheglo D., Schwab M., Savelyeva L. The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers. Hum. Mol. Genet. 2011, 20:1488-1501.
35. Lai L.A., Kostadinov R., Barrett M.T., Peiffer D.A., Pokholok D., Odze R., Sanchez C.A., Maley C.C., Reid B.J., Gunderson K.L., Rabinovitch P.S. Deletion at fragile sites is a common and early event in Barrett's esophagus. Mol. Cancer Res. 2010, 8:1084-1094.
36. Hormozian F., Schmitt J.G., Sagulenko E., Schwab M., Savelyeva L. FRA1E common fragile site breaks map within a 370kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD). Cancer Lett. 2007, 246:82-91.
37. Limongi M.Z., Pelliccia F., Rocchi A. Characterization of the human common fragile site FRA2G. Genomics 2003, 81:93-97.
38. Brueckner L.M., Sagulenko E., Hess E.M., Zheglo D., Blumrich A., Schwab M., Savelyeva L. Genomic rearrangements at the FRA2H common fragile site frequently involve non-homologous recombination events across LTR and L1 (LINE) repeats. Hum. Genet. 2012, 131:1345-1359.
39. Wilke C.M., Guo S.W., Hall B.K., Boldog F., Gemmill R.M., Chandrasekharappa S.C., Barcroft C.L., Drabkin H.A., Glover T.W. Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma. Genomics 1994, 22:319-326.
40. Zimonjic D.B., Druck T., Ohta M., Kastury K., Croce C.M., Popescu N.C., Huebner K. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res. 1997, 57:1166-1170.
41. Helmrich A., Stout-Weider K., Matthaei A., Hermann K., Heiden T., Schrock E. Identification of the human/mouse syntenic common fragile site FRA7K/Fra12C1-relation of FRA7K and other human common fragile sites on chromosome 7 to evolutionary breakpoints. Int. J. Cancer 2007, 120:48-54.
42. Sawinska M., Schmitt J.G., Sagulenko E., Westermann F., Schwab M., Savelyeva L. Novel aphidicolin-inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene. Genes Chromosomes Cancer 2007, 46:991-999.
43. Savelyeva L., Sagulenko E., Schmitt J.G., Schwab M. The neurobeachin gene spans the common fragile site FRA13A. Hum. Genet. 2006, 118:551-558.
44. Mangelsdorf M., Ried K., Woollatt E., Dayan S., Eyre H., Finnis M., Hobson L., Nancarrow J., Venter D., Baker E., Richards R.I. Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res. 2000, 60:1683-1689.
45. Arlt M.F., Miller D.E., Beer D.G., Glover T.W. Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosomes Cancer 2002, 33:82-92.
46. Sutherland G.R. Rare fragile sites. Cytogenet. Genome Res. 2003, 100:77-84.
47. Schwartz M., Zlotorynski E., Kerem B. The molecular basis of common and rare fragile sites. Cancer Lett. 2006, 232:13-26.
48. Smith D.I., McAvoy S., Zhu Y., Perez D.S. Large common fragile site genes and cancer. Semin. Cancer Biol. 2007, 17:31-41.
49. Helmrich A., Ballarino M., Tora L. Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol. Cell 2011, 44:966-977.
50. Le Tallec B., Dutrillaux B., Lachages A.M., Millot G.A., Brison O., Debatisse M. Molecular profiling of common fragile sites in human fibroblasts. Nat. Struct. Mol. Biol. 2011, 18:1421-1423.
51. Bruderlein S., van der Bosch K., Schlag P., Schwab M. Cytogenetics and DNA amplification in colorectal cancers. Genes Chromosomes Cancer 1990, 2:63-70.
52. Henegariu O., Bray-Ward P., Ward D.C. Custom fluorescent-nucleotide synthesis as an alternative method for nucleic acid labeling. Nat. Biotechnol. 2000, 18:345-348.
53. Kent W.J. BLAT - the BLAST-like alignment tool. Genome Res. 2002, 12:656-664.
54. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., Haussler D. The human genome browser at UCSC. Genome Res. 2002, 12:996-1006.
55. Debatisse M., El Achkar E., Dutrillaux B. Common fragile sites nested at the interfaces of early and late-replicating chromosome bands: cis acting components of the G2/M checkpoint?. Cell Cycle 2006, 5:578-581.
56. Barretina J., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012, 483:603-607.
57. Arlt M.F., Ozdemir A.C., Birkeland S.R., Lyons R.H., Glover T.W., Wilson T.E. Comparison of constitutional and replication stress-induced genome structural variation by SNP array and mate-pair sequencing. Genetics 2011, 187:675-683.
58. Nguyen D.Q., Webber C., Ponting C.P. Bias of selection on human copy-number variants. PLoS Genet. 2006, 2:e20.
59. Smit A.F. Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr. Opin. Genet. Dev. 1999, 9:657-663.
60. Debacker K., Winnepenninckx B., Ben-Porat N., FitzPatrick D., Van Luijk R., Scheers S., Kerem B., Frank Kooy R. FRA18C: a new aphidicolin-inducible fragile site on chromosome 18q22, possibly associated with in vivo chromosome breakage. J. Med. Genet. 2007, 44:347-352.
61. Zhang H., Freudenreich C.H. An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cerevisiae. Mol. Cell 2007, 27:367-379.
62. Shah S.N., Opresko P.L., Meng X., Lee M.Y., Eckert K.A. DNA structure and the Werner protein modulate human DNA polymerase delta-dependent replication dynamics within the common fragile site FRA16D. Nucl. Acids Res. 2010, 38:1149-1162.
63. Birnbaum D., Adelaide J., Popovici C., Charafe-Jauffret E., Mozziconacci M.J., Chaffanet M. Chromosome arm 8p and cancer: a fragile hypothesis. Lancet Oncol. 2003, 4:639-642.
64. Akasaka T., Balasas T., Russell L.J., Sugimoto K.J., Majid A., Walewska R., Karran E.L., Brown D.G., Cain K., Harder L., Gesk S., Martin-Subero J.I., Atherton M.G., Bruggemann M., Calasanz M.J., Davies T., Haas O.A., Hagemeijer A., Kempski H., Lessard M., Lillington D.M., Moore S., Nguyen-Khac F., Radford-Weiss I., Schoch C., Struski S., Talley P., Welham M.J., Worley H., Strefford J.C., Harrison C.J., Siebert R., Dyer M.J. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 2007, 109:3451-3461.
65. Sarkar T.R., Sharan S., Wang J., Pawar S.A., Cantwell C.A., Johnson P.F., Morrison D.K., Wang J.M., Sterneck E. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPdelta expression and contributes to transformation of breast tumor cells. Mol. Cell. Biol. 2012, 32:320-332.
66. Wang J., Sarkar T.R., Zhou M., Sharan S., Ritt D.A., Veenstra T.D., Morrison D.K., Huang A.M., Sterneck E. CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 2010, 107:16131-16136.
67. Lee J.A., Carvalho C.M., Lupski J.R. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 2007, 131:1235-1247.
68. McVey M., Lee S.E. MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet. 2008, 24:529-538.
69. Hoppe B.S., Jensen R.B., Kirchgessner C.U. Complementation of the radiosensitive M059J cell line. Radiat. Res. 2000, 153:125-130.
70. Allen C., Ashley A.K., Hromas R., Nickoloff J.A. More forks on the road to replication stress recovery. J. Mol. Cell. Biol. 2011, 3:4-12.
71. F. Mitelman, B. Johansson, F. Mertens, Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, 2013. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
72. Labib K., Hodgson B. Replication fork barriers: pausing for a break or stalling for time?. EMBO Rep. 2007, 8:346-353.
73. Inoue H., Ishii H., Alder H., Snyder E., Druck T., Huebner K., Croce C.M. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. USA 1997, 94:14584-14589.
74. Mimori K., Druck T., Inoue H., Alder H., Berk L., Mori M., Huebner K., Croce C.M. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc. Natl. Acad. Sci. USA 1999, 96:7456-7461.
75. Barlow J.H., Faryabi R.B., Callen E., Wong N., Malhowski A., Chen H.T., Gutierrez-Cruz G., Sun H.W., McKinnon P., Wright G., Casellas R., Robbiani D.F., Staudt L., Fernandez-Capetillo O., Nussenzweig A. Identification of early replicating fragile sites that contribute to genome instability. Cell 2013, 152:620-632.